Three themes define the quarter: the rate window opening for first-mover listings, VHP's active pipeline entering the execution phase, and institutional demand at its highest since 2021.
"VHP was built on a specific observation: that the most significant capital markets opportunity in the world right now is not in the transactions that established firms are competing for. It is in the companies they cannot reach. The emerging market businesses that have achieved genuine institutional scale, carry credible backing, and are ready for a public listing, but whose size or geography places them below the threshold of the advisors who would otherwise serve them. We built the infrastructure to serve those companies. The conversations that listings are built from are happening now."
The S&P 500 ended the quarter broadly flat following significant intra-quarter volatility driven by Federal Reserve communications on rate normalisation. The Nasdaq Composite outperformed marginally, supported by continued institutional demand for high-growth technology and AI infrastructure companies where earnings visibility is improving.
The IPO market showed selective recovery. Transaction volumes increased quarter-on-quarter but remain below the 2021 cycle peak. The defining characteristic is bifurcation: companies with proven revenue models, institutional backing, and clear paths to profitability are being well received; pre-revenue companies face a more demanding institutional audience.
For the companies in VHP's origination pipeline, this environment is directly constructive.
The LSE continued its structural reform agenda. The FCA's PISCES framework creates new private company share trading mechanisms that reduce friction between private and public markets — a positive development for international issuers building their UK institutional investor base ahead of formal listing.
European institutional demand for emerging market public equity exposure remains structural and is not abating. VHP's UK execution partnerships are confirmed and expanding through engagement with additional mid-market partners.
The companies that understand the international listing premium and act in the current window will set the valuation benchmarks that every company in their category references for years.
The impact on VHP's pipeline. Declining rates historically produce multiple expansion in growth company valuations and increased institutional appetite for emerging market equities as the risk-free rate compresses.
Companies listing into a normalising rate environment capture better valuations than those that listed at peak rates in 2022 and 2023. VHP's pipeline is positioned to benefit from this dynamic in Q3 and Q4 2026.
For emerging market listings specifically, the compression of the risk-free rate structurally improves the relative attractiveness of higher-growth assets. The first-mover positioning of VHP's active mandates means they capture the opening of this window ahead of any subsequent deal flow.
Payments infrastructure combining high-frequency transaction volume with working capital products maintained strong institutional interest. Fund lifecycle pressure is creating specific near-term listing momentum for a select group of African fintech companies.
Scalable technology-enabled healthcare delivery attracted increasing institutional attention as the post-pandemic focus on health system resilience translated into investment appetite. Diagnostic networks, pharmacy platforms, and digital health records are the most consistently sought profiles.
African B2B logistics infrastructure with institutional backing and multi-country operations attracted meaningful investor interest as the supply chain resilience narrative continued to drive capital allocation toward the sector.
Chrome pricing stabilised following Q1 volatility. Higher grade concentrate commanded meaningful premiums as Southern African supply constraints tightened effective export volumes. Copper maintained strength driven by energy transition structural demand.